Butyric Acid

Butyric Acid

SCHEMBL3238982

CCCC(=O)O.[Ar]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyric Acid SCHEMBL1330379 0.96
Butyric Acid SCHEMBL320515 0.96 FFAR3 (1.00)
Butyric Acid SCHEMBL4446516 0.96 FFAR3 (1.00)
Butyric Acid SCHEMBL991717 0.96 FFAR3 (1.00)
Butyric Acid SCHEMBL339305 0.96 FFAR3 (1.00)
Butyric Acid SCHEMBL5703921 0.96 FFAR3 (1.00)
Butyric Acid SCHEMBL8458708 0.96 FFAR3 (1.00)
Butyric Acid SCHEMBL8457839 0.96 FFAR3 (1.00)
Butyric Acid SCHEMBL20678495 0.96
Butyric Acid SCHEMBL1332215 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745438-B2 3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and their use as bace inhibitors ELI LILLY AND COMPANY (US) 2010-06-29 US disclosed
EP-2091928-A2 3-(2-ACYLAMINO-1-HYDROXYETHYL)- MORPHOLINE DERIVATIVES AND THEIR USE AS BACE INHIBITORS ELI LILLY AND COMPANY (US) 2009-08-26 EP disclosed
US-20070225267-A1 3-(2-Acylamino-1-Hydroxyethyl)-Morpholine Derivatives and Their Use as Bace Inhibitors ELI LILLY AND COMPANY 2007-09-27 US disclosed
WO-2006034093-A2 3- (2-ACYLAMINO-1-HYDROXYETHYL)- MORPHOLINE DERIVATIVES AND THEIR USE AS BACE INHIBITORS ELLI LILLY AND COMPANY (US) 2006-03-30 WO disclosed